Microbot Medical (MBOT) Current Deferred Revenue (2011 - 2025)

Microbot Medical (MBOT) reported Current Deferred Revenue of $93000.0 for Q4 2025, up 452.72% quarter-over-quarter from $16826.0 in Q3 2016.

Microbot Medical (MBOT) Current Deferred Revenue (2011 - 2025) Analysis & Trends

Microbot Medical has reported Current Deferred Revenue for 7 years, with the latest figure at $93000.0 in Q4 2025.

For the quarter ending Q4 2025, Current Deferred Revenue changed N/A year-over-year to $93000.0; the trailing twelve-month figure through Dec 2025 stood at $93000.0 (changed N/A YoY), and the FY2025 full-year result was $93000.0, changed N/A from the prior year.
Current Deferred Revenue for Q4 2025 stood at $93000.0, up from $16826.0 in the prior quarter.
The five-year high for Current Deferred Revenue was $93000.0 in Q4 2025, with the low at $93000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Microbot Medical	122.56 Mn	52.91 Mn	2,000.00

Download Data